Wecome Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.001x

Wecome Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Wecome Pharmaceutical Co Ltd (300878) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.42 Million ≈ $-208.32K USD) by net assets (CN¥1.03 Billion ≈ $150.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Wecome Pharmaceutical Co Ltd (2013–2024)

Cash flow conversion efficiency of Wecome Pharmaceutical Co Ltd from 2013 to 2024. This chart illustrates how Wecome Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Wecome Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.

Wecome Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Wecome Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Wecome Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wecome Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Wecome Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
SILEX Systems Ltd AU:SLX	0.027x
Guangdong Sunwill Precising Plastic Co Ltd SHE:002676	0.060x
Shaanxi Construction Machinery Co Ltd SHG:600984	0.029x
Ningbo David Medical Device Co Ltd SHE:300314	0.119x
DRI Healthcare Trust TO:DHT-U	0.053x
Greenlam Industries Limited NSE:GREENLAM	0.130x
Neto Malinda TA:NTML	-0.090x
Suzhou Electrical Apparatus Sci SHE:300215	0.047x

Annual Cash Flow Conversion Efficiency for Wecome Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Wecome Pharmaceutical Co Ltd from 2013 to 2024. Review free cash flow generation of Wecome Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.17 Billion ≈ $171.77 Million	CN¥-27.17 Million ≈ $-3.98 Million	-0.023x	-155.89%
2023-12-31	CN¥1.41 Billion ≈ $205.95 Million	CN¥58.29 Million ≈ $8.53 Million	0.041x	-60.11%
2022-12-31	CN¥1.41 Billion ≈ $206.55 Million	CN¥146.57 Million ≈ $21.45 Million	0.104x	+315.97%
2021-12-31	CN¥1.41 Billion ≈ $206.18 Million	CN¥-67.74 Million ≈ $-9.91 Million	-0.048x	-255.47%
2020-12-31	CN¥1.38 Billion ≈ $202.58 Million	CN¥42.81 Million ≈ $6.26 Million	0.031x	-85.74%
2019-12-31	CN¥519.84 Million ≈ $76.07 Million	CN¥112.76 Million ≈ $16.50 Million	0.217x	-19.08%
2018-12-31	CN¥393.83 Million ≈ $57.63 Million	CN¥105.57 Million ≈ $15.45 Million	0.268x	+182.87%
2017-12-31	CN¥306.05 Million ≈ $44.79 Million	CN¥29.00 Million ≈ $4.24 Million	0.095x	-80.04%
2016-12-31	CN¥210.90 Million ≈ $30.86 Million	CN¥100.15 Million ≈ $14.66 Million	0.475x	+108.41%
2015-12-31	CN¥130.04 Million ≈ $19.03 Million	CN¥29.63 Million ≈ $4.34 Million	0.228x	-61.26%
2014-12-31	CN¥78.22 Million ≈ $11.45 Million	CN¥46.01 Million ≈ $6.73 Million	0.588x	-22.24%
2013-12-31	CN¥34.35 Million ≈ $5.03 Million	CN¥25.98 Million ≈ $3.80 Million	0.756x	--

About Wecome Pharmaceutical Co Ltd

SHE:300878 China Biotechnology

Market Cap

$593.88 Million

CN¥4.06 Billion CNY

Market Cap Rank

#11057 Global

#3014 in China

Share Price

CN¥28.03

Change (1 day)

+0.94%

52-Week Range

CN¥20.68 - CN¥39.45

All Time High

CN¥52.21